Hearing group Demant is going on a hunt for a new president for its surgical division, Oticon Medical, which has marketed hearing implants and bone-anchored solutions since the company’s establishment in 2008.
Jes Olsen, who has been at the Demant group since 1985 and has spearheaded Oticon Medical from the beginning, has decided to retire from the company at the beginning of March, Demant reports in a press release on Tuesday.
More from MedWatch
In 2015, Genmab partnered with relatively unknown biotech firm Biontech. Reflecting on how far Genmab has come since, CEO Jan van de Winkel is still confident that partnerships, rather than acquisitions, are the way forward. If it had acquired Biontech at the time, the CEO speculates Genmab may have put a stop to other activities – including the Covid-19 vaccine efforts that went on to save millions of lives. This and fairness are worth remembering as biotech firms are increasingly strapped for cash, van de Winkel reflects.